FINAL kissing balloon dilatation (FKB) in patients treated with an upfront provisional stenting strategy for coronary ...

Most patients with VAO stenosis refractory to medical treatment are treated endovascularly using stenting. To optimally cover the ostial plaque, which frequently extends into the adjacent subclavian ...

The first reported use of SEMS for malignant GOO was in the early 1990s. [2] Contraindications to gastroduodenal stent placement include known or suspected enteral ischemia or perforation ...

While plastic stents were first used to treat gastrointestinal conditions of the esophagus, gastroduodenal, biliary ducts, and colon, bare-metal stent advancements led to their use for these ...

Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in the months following the procedure. While routine ...

Conclusion: This study demonstrates the successful management of a super-high esophageal-tracheal fistula using a Sigma fully covered metallic stent. Super-high esophageal fistulas occur in the upper ...

Background The impact of stent retriever size on mechanical thrombectomy (MT) outcomes remains uncertain. We aim to clarify the influence of stent retriever size on MT outcomes by analyzing data from ...

SUFFERN, N.Y., March 25, 2025 /PRNewswire/ -- CDx Diagnostics today announced that in the continued evolution of the WATS 3D test as a tool in the fight against esophageal cancer, Dr. Sidney ...

SUFFERN, N.Y., March 25, 2025 /PRNewswire/ -- CDx Diagnostics today announced that in the continued evolution of the WATS 3D test as a tool in the fight against esophageal cancer, Dr. Sidney Olefson ...

The spotlight of this year's exhibit will be the ARP-93A-B20 WHITE L and ARP-95A-B20 WHITE L, specifically engineered for ureteral stents. These innovative TPU materials meet ISO 10993 standards ...

Tevimbra is also indicated for esophageal cancer as monotherapy in adults with unresectable or metastatic ESCC after prior systemic chemotherapy that did not include a PD-L1 inhibitor, and in ...